Tools
Effective Health Care Research Consortium (2010) Is azithromycin better than current first-line treatments for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review. Liverpool, Effective Health Care Research Consortium, Liverpool School of Tropical Medicine.
|
Text
OtherInfDiseases_CD006083_Jan10_Final_000.pdf - Published Version Available under License Creative Commons Attribution No Derivatives. Download (148kB) |
Official URL: http://www.liv.ac.uk/evidence/documents/OtherInfDi...
Abstract
Azithromycin is at least as good as fluoroquinolones, but more expensive.
Item Type: | Other |
---|---|
Corporate Authors: | Effective Health Care Research Consortium |
Additional Information: | Produced by the Effective Health Care Research Consortium (www.liv.ac.uk/evidence), Liverpool School of Tropical Medicine, supported by the Department for International Development UK. Adapted from Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006083. DOI: 10.1002/14651858.CD006083.pub2. Evidence Update published in January 2010. |
Uncontrolled Keywords: | Cochrane Review CD006083, Azithromycin, Typhoid and Paratyphoid fever, other infectious diseases, Evidence Update |
Subjects: | WA Public Health > WA 20.5 Research (General) WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 266 Paratyphoid fevers WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 270 Typhoid fever |
Faculty: Department: | Groups (2002 - 2012) > International Health Group |
Related URLs: | |
Depositing User: | Faye Moody |
Date Deposited: | 27 Aug 2010 11:13 |
Last Modified: | 06 Feb 2018 13:01 |
URI: | https://archive.lstmed.ac.uk/id/eprint/1320 |
Statistics
Actions (login required)
Edit Item |